MediSieve is a biotech developing a novel Magnetic Blood Filtration technology. Our nanoengineered magnetic particles enable the selective removal of specific substances - such as pathogens, antibodies, and inflammatory cytokines - from the bloodstream, much like dialysis, but with unmatched precision.
Our platform's versatility allows for the selective removal of virtually any target, with our lead asset focused on neutralising antibody (NAb) removal to enhance AAV gene therapies for both initial dosing and redosing.
Company Details
- Employees
- 10
- Founded
- 2015
- Address
- 80 Wood Lane, London,england W12 0bz,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.medisieve.com
- HQ
- London, England
Medisieve Questions
Medisieve's website is http://www.medisieve.com
Medisieve's LinkedIn profile is https://uk.linkedin.com/company/medisieve
Medisieve has
10 employees.
View email and phone details for 10
employees at Medisieve.
Medisieve's industry is
Biotechnology Research
Medisieve's top competitors are
Refeyn,
Immuone,
Ignota Labs,
Mina Therapeutics,
Aviadobio,
Mesox,
Vitarka Therapeutics,
Sixfold Bioscience,
Ambrose Healthcare,
24haymarket.
Medisieve's categories are Biotechnology Research
Medisieve's founding year is 2015
